Nash S

No ORCID on file · 2 papers in corpus
letter 2022
The Journal of Pathology ·doi:10.1002/path.5973

The ARID1A tumour suppressor protein is a component of the SWI/SNF chromatin remodelling complex, which is mutated in approximately 20% of all human cancers. ARID1A mutational status is considered to hold prognostic significance in a range …

2021
Cancers ·doi:10.3390/cancers13153854

Ovarian clear cell carcinoma (OCCC) is a rare subtype of epithelial ovarian cancer characterised by a high frequency of loss-of-function ARID1A mutations and a poor response to chemotherapy. Despite their generally low mutational burden, an…